SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001610618-18-000079
Filing Date
2018-07-31
Accepted
2018-07-31 16:06:43
Documents
2
Period of Report
2018-07-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K a8-k2018x07x31.htm 8-K 23347
2 SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT exhibit101secondamendmentt.htm EX-10.1 24980
  Complete submission text file 0001610618-18-000079.txt   49585
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36912 | Film No.: 18981169
SIC: 2836 Biological Products, (No Diagnostic Substances)